Target intelligence / Profile preview

Peptidase M20 domain containing 2 (PM20D2)

Target
PM20D2
Molecular classification
Enzyme, Metalloenzyme, Metallopeptidase 20 family
01

Overview

Peptidase M20 domain containing 2 (PM20D2) is a metalloenzyme in the metallopeptidase 20 family that acts as a “metabolite repair” enzyme, especially in tissues with active carnosine synthase such as muscle, heart, and brain. Its main role is to hydrolyze noncanonical dipeptides—particularly those derived from β-alanine and γ-aminobutyrate linked to basic amino acids (lysine, ornithine, arginine)—which are produced as byproducts when carnosine synthase uses alternative substrates. PM20D2 thereby prevents their accumulation, ensuring the synthesis of physiologically relevant dipeptides like carnosine and homocarnosine, and contributes to metabolic regulation and dipeptide homeostasis. Human PM20D2 displays 100–200 fold lower enzymatic activity compared to mouse PM20D2[1][4][7].

Other names
BA63L7.3ACY1L2Xaa-Arg dipeptidaseBeta-Ala-Lys dipeptidaseβ-alanyl-lysine dipeptidaseaminoacylase-1-like protein 2xaa-Arg dipeptidaseI(2)-alanyl-lysine dipeptidase
02

Biological functions

Dipeptidase activityProteolysisRegulation of protein metabolic processesMetabolite repair in tissues where carnosine synthase operates

Beyond the preview

Go deeper on Peptidase M20 domain containing 2 (PM20D2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidase M20 domain containing 2 (PM20D2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call